Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different doses of aminocaproic acid in perioperative bleeding and blood transfusion during cardiopulmonary bypass cardiac surgery
ChiCTR2400088592Phase 4Not yet recruiting
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of aminocaproic acid in perioperative hemorrhage and Bleeding (2 arms), sponsored by The Affiliated Hospital of Qingdao University. Primary endpoint: Bleeding amount within 24 hours after surgery. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
aminocaproic acid
03
Conditions
perioperative hemorrhageBleeding
Beyond the preview
Go deeper on ChiCTR2400088592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088592.